NioCorp Developments (NB) Earnings Analysis
NioCorp Developments (NB) has no confirmed upcoming earnings date. Last quarter (2026-05-14) it beat with EPS -0.02 USD vs -0.02 USD est (0%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -6.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NB next report earnings?
No confirmed upcoming earnings date is currently scheduled for NB. This page updates as the calendar is published.
NB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.02 USD | -0.02 USD | 0% | Beat |
| 2026-02-06 | -0.05 USD | -0.05 USD | 0% | Beat |
| 2025-11-13 | -0.11 USD | -0.09 USD | -22.2% | Miss |
| 2025-09-22 | -0.2 USD | -0.17 USD | -17.6% | Miss |
| 2025-02-07 | -0.01 USD | -0.01 USD | 0% | Beat |
| 2024-11-13 | -0.05 USD | -0.05 USD | 0% | Beat |
| 2024-09-23 | -0.53 USD | n/a | n/a | n/a |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
NB valuation and analyst view
| Trailing P/E | -6.24 |
|---|---|
| Trailing EPS | -0.37467 USD |
| Price / book | 1.36 |
| Dividend yield | 0.00% |
| Market cap | 0.65B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 9.86 USD |
Related research pages
Frequently asked questions
When is NioCorp Developments (NB)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NB. This page updates as the calendar is published.
Did NB beat earnings last quarter?
In its 2026-05-14 report, NB posted EPS of -0.02 USD versus a -0.02 USD estimate — a beat of 0%.
What is NB's earnings track record?
Over the last 6 reported quarters with consensus data, NB beat estimates 4 times (67%).
What is NB's current P/E ratio and EPS?
NB trades at a trailing P/E of -6.24 on trailing EPS of -0.3746655734107666 USD.
What do analysts rate NB?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 9.86 USD.